Advertisement
CVE vs XOM
Which Stock Would AI Choose? Cenovus Energy (CVE) vs. ExxonMobil (XOM) Stock Comparison
Key Takeaways
- Cenovus Energy (CVE) is a Canadian oil sands-focused integrated producer whose recent performance has been driven by acquisitions and production growth, but which now faces a deleveraging phase and reduced shareholder-return commitments.
- ExxonMobil (XOM) is one of the world's largest integrated energy and chemicals companies, trading near record highs on strong cash flow, Guyana and Permian growth, and a sharp rally in crude prices.
- Both names have posted strong relative performance, but CVE trades at a meaningful valuation discount and carries higher commodity-price sensitivity than XOM.
- XOM offers greater scale, diversification, and lower volatility, while CVE offers more torque to oil prices and an execution-driven turnaround story.
- For more on each name's major developments and intraday activity, explore the CVE Major News and CVE Today's Price Move pages, as well as XOM Major News and XOM Today's Price Move.
- To see how automated systems are positioning across these and thousands of other tickers, explore the Trending AI Robots.
Introduction
This stock comparison examines two integrated energy producers operating at very different scales: Cenovus Energy, a Canadian oil sands specialist, and ExxonMobil, a global supermajor. Both companies sit squarely within the same commodity cycle, yet their market positioning, risk profiles, and growth drivers differ considerably. Investors weighing relative performance between a higher-beta, execution-focused turnaround story and a diversified, lower-volatility industry leader may find this comparison useful. By evaluating recent momentum, business mix, balance-sheet dynamics, and sector exposure, readers can better understand how CVE and XOM compare in the current market environment.
CVE Overview and Recent Performance
Cenovus Energy (CVE) is a Calgary-based integrated oil and natural gas company with a heavy concentration in Alberta's oil sands, complemented by refining and upgrading assets. In recent quarters the company has used acquisitions to scale up, closing its takeover of rival MEG Energy and announcing a further deal for Athabasca Oil, moves that expand its thermal production footprint and reserve life. These transactions have supported a strong multi-month share rally and helped the stock outperform much of its Canadian peer group.
That momentum, however, has come with trade-offs. To fund the deals, Cenovus has taken on significantly more debt, and management has scaled back its shareholder-return commitment from returning all excess free cash flow to roughly half, directing the remainder toward debt repayment. The stock's forward valuation remains inexpensive relative to the broader integrated-oil industry, but its realized pricing is closely tied to Western Canadian Select (WCS) heavy crude and its cash flows are highly sensitive to West Texas Intermediate (WTI) movements. Recent sentiment has been constructive on execution and synergy potential, while tempered by leverage and commodity-price risk.
XOM Overview and Recent Performance
ExxonMobil (XOM) is among the world's largest integrated energy and chemical companies, spanning upstream production, refining, chemicals, and specialty products across most major markets. Recent performance has been strong, with the shares advancing toward record levels on a combination of elevated crude prices, record output in the Permian Basin, and rapid growth in offshore Guyana, where production has scaled up materially and a fifth floating production vessel is expected to start up before year-end.
The company has also benefited from durable cost discipline, reporting billions in cumulative structural cost savings since 2019. Recent quarters showed robust operating and free cash flow, supporting a long track record of annual dividend increases alongside ongoing buybacks. Like all refiners and producers, XOM remains exposed to swings in commodity prices, product spreads, and geopolitical supply disruptions, but its diversified asset base and lower beta have historically made its share-price moves less volatile than those of smaller, more concentrated producers.
Trending AI Robots
Tickeron maintains a large library of AI trading bots that collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, and performance statistics. Because market conditions change, not every bot is suited to every environment, which is why Tickeron curates a Trending AI Robots section focused on the bots best aligned with current conditions. This curated view lets traders quickly surface strategies showing recent strength rather than sifting through the full catalog. If you want to see how automated systems are currently positioning across names like CVE and XOM, the Trending AI Robots page is a practical place to start.
Head-to-Head Comparison
The most fundamental contrast between these two stocks is scale and diversification. XOM operates across global upstream, refining, and chemicals segments, giving it multiple levers to generate cash in different price environments. CVE is far more concentrated, with results heavily influenced by Canadian heavy crude pricing and oil sands economics. This concentration means Cenovus offers greater upside torque when oil prices rise, but more pronounced downside when prices or differentials weaken.
Growth drivers also differ. ExxonMobil's expansion is organic and project-driven, anchored in Permian and Guyana development and efficiency gains, whereas Cenovus's recent growth has come through acquisitions that raised debt and temporarily reduced shareholder payouts. On valuation, CVE trades at a lower forward price-to-earnings multiple, reflecting higher perceived risk, while XOM commands a premium for its stability and scale. From a sentiment standpoint, both enjoy analyst support, but ExxonMobil's steadier, lower-beta profile contrasts with Cenovus's more volatile, catalyst-dependent trajectory.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely express a preference for XOM on a trend-consistency and stability basis, given its established uptrend, diversified cash flows, and relatively contained volatility. That said, the assessment is not one-sided: CVE may present a more compelling risk-adjusted setup on valuation and momentum metrics, especially if oil prices remain firm and its integration and deleveraging plans proceed as expected. The relative outlook ultimately hinges on whether investors prioritize steady, diversified positioning or higher-beta exposure to the commodity cycle, and the AI's stance could shift as momentum, catalysts, and price trends evolve.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVE is a Buy and XOM is a Buy.
CVE in upward trend: 10-day moving average crossed above 50-day moving average on October 13, 2026
The 10-day moving average for CVE crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVE advanced for three days, in 271 of 354 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 237 of 291 cases where CVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 69 cases where CVE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVE as a result. In 64 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for CVE turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 35 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
CVE moved below its 50-day moving average on October 27, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
CVE broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 28 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 26, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.707) is normal, around the industry mean (1.707). P/E Ratio (8.794) is within average values for comparable stocks, (11.466). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.088). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. P/S Ratio (1.435) is also within normal values, averaging (3.764).
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Momentum Indicator for XOM turns positive, indicating new upward trend
XOM saw its Momentum Indicator move above the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 59 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for XOM just turned positive on October 06, 2026. Looking at past instances where XOM's MACD turned positive, the stock continued to rise in 30 of 50 cases over the following month. The odds of a continued upward trend are 60%.
Following a +3.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where XOM advanced for three days, in 232 of 373 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 192 of 312 cases where XOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
Bearish Trend Analysis
The 10-day RSI Indicator for XOM moved out of overbought territory on October 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 27 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 18 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
XOM broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 26, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. XOM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XOM's P/B Ratio (2.852) is slightly higher than the industry average of (1.707). XOM has a moderately high P/E Ratio (23.154) as compared to the industry average of (11.466). Projected Growth (PEG Ratio) (1.392) is also within normal values, averaging (1.088). Dividend Yield (0.023) settles around the average of (0.047) among similar stocks. P/S Ratio (1.911) is also within normal values, averaging (3.764).
CVE | XOM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 79 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 48 Fair valued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 28 | 4 | |
SMR RATING 1..100 | 45 | 62 | |
PRICE GROWTH RATING 1..100 | 37 | 6 | |
P/E GROWTH RATING 1..100 | 86 | 10 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVE's Valuation (48) in the Oil And Gas Production industry is somewhat better than the same rating for XOM (85) in the Integrated Oil industry. This means that CVE’s stock grew somewhat faster than XOM’s over the last 12 months.
XOM's Profit vs Risk Rating (4) in the Integrated Oil industry is in the same range as CVE (28) in the Oil And Gas Production industry. This means that XOM’s stock grew similarly to CVE’s over the last 12 months.
CVE's SMR Rating (45) in the Oil And Gas Production industry is in the same range as XOM (62) in the Integrated Oil industry. This means that CVE’s stock grew similarly to XOM’s over the last 12 months.
XOM's Price Growth Rating (6) in the Integrated Oil industry is in the same range as CVE (37) in the Oil And Gas Production industry. This means that XOM’s stock grew similarly to CVE’s over the last 12 months.
XOM's P/E Growth Rating (10) in the Integrated Oil industry is significantly better than the same rating for CVE (86) in the Oil And Gas Production industry. This means that XOM’s stock grew significantly faster than CVE’s over the last 12 months.
| CVE | XOM | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 66% |
| Stochastic ODDS (%) | 1 day ago 65% | 1 day ago 52% |
| Momentum ODDS (%) | 1 day ago 70% | 1 day ago 65% |
| MACD ODDS (%) | 1 day ago 70% | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 64% |
| Advances ODDS (%) | 3 days ago 77% | 3 days ago 62% |
| Declines ODDS (%) | 7 days ago 66% | 9 days ago 44% |
| BollingerBands ODDS (%) | 1 day ago 59% | 1 day ago 50% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 62% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVE’s FA Score shows that 1 FA rating(s) are green while XOM’s FA Score has 3 green FA rating(s).
- CVE’s FA Score: 1 green, 4 red.
- XOM’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVE’s TA Score shows that 3 TA indicator(s) are bullish while XOM’s TA Score has 4 bullish TA indicator(s).
- CVE’s TA Score: 3 bullish, 6 bearish.
- XOM’s TA Score: 4 bullish, 4 bearish.
Price Growth
CVE (@Integrated Oil) experienced а -4.55% price change this week, while XOM (@Integrated Oil) price change was +1.15% for the same time period.
The average weekly price growth across all stocks in the @Integrated Oil industry was -1.90%. For the same industry, the average monthly price growth was +3.55%, and the average quarterly price growth was +3.00%.
Reported Earning Dates
CVE is expected to report earnings on Oct 30, 2026.
XOM is expected to report earnings on Oct 30, 2026.
Industries' Descriptions
@Integrated Oil (-1.90% weekly)Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.
Advertisement
CVE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVE has been closely correlated with SU. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVE jumps, then SU could also see price increases.
| Ticker / NAME | Correlation To CVE | 1D Price Change % | ||
|---|---|---|---|---|
| CVE | 100% | -4.58% | ||
| SU - CVE | 82% Closely correlated | -4.10% | ||
| CRGY - CVE | 78% Closely correlated | -1.37% | ||
| IMO - CVE | 77% Closely correlated | -4.21% | ||
| EQNR - CVE | 73% Closely correlated | -2.16% | ||
| BP - CVE | 73% Closely correlated | -3.17% | ||
More | ||||